Osaic Holdings’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Osaic Holdings’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,631	Closed	-$73K	–	7502
2021 Q2	$73K	Buy	2,631 +1,224	+87%	+$24.1K	﹤0.01%	4761
2021 Q1	$23K	Buy	1,407 +623	+79%	+$14.2K	﹤0.01%	5400
2020 Q4	$16K	Buy	784 +284	+57%	+$5.08K	﹤0.01%	5307
2020 Q3	$7K	Buy	500 +32	+7%	+$493	﹤0.01%	5473
2020 Q2	$9K	Buy	468 +21	+5%	+$317	﹤0.01%	5257
2020 Q1	$5K	Buy	+447	New	+$3.66K	﹤0.01%	5383

Osaic Holdings's TBIO Position: Q3 2021 in Review

Osaic Holdings sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 2,631 shares — an estimated $73K sold.

Osaic Holdings first reported a position in TBIO in Q1 2020 and held it in 6 quarters. The position peaked at $73K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Osaic Holdings reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Osaic Holdings sold 2,631 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $73K.
Osaic Holdings first reported a position in Translate Bio, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
Osaic Holdings's Translate Bio, Inc. Common Stock position peaked at $73K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Osaic Holdings's 13F filing for Q3 2021, filed 5 Nov 2021.